SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-001326
Filing Date
2024-08-13
Accepted
2024-08-12 18:21:00
Documents
87
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q derm-20240630x10q.htm   iXBRL 10-Q 1801117
2 EX-31.1 derm-20240630xex31d1.htm EX-31.1 11886
3 EX-31.2 derm-20240630xex31d2.htm EX-31.2 11775
4 EX-32.1 derm-20240630xex32d1.htm EX-32.1 5475
5 EX-32.2 derm-20240630xex32d2.htm EX-32.2 5435
  Complete submission text file 0001410578-24-001326.txt   7686520

Data Files

Seq Description Document Type Size
6 EX-101.SCH derm-20240630.xsd EX-101.SCH 58880
7 EX-101.CAL derm-20240630_cal.xml EX-101.CAL 65389
8 EX-101.DEF derm-20240630_def.xml EX-101.DEF 236598
9 EX-101.LAB derm-20240630_lab.xml EX-101.LAB 497342
10 EX-101.PRE derm-20240630_pre.xml EX-101.PRE 384739
90 EXTRACTED XBRL INSTANCE DOCUMENT derm-20240630x10q_htm.xml XML 1246918
Mailing Address 9237 E VIA DE VENTURA BLVD., SUITE 105 SCOTTSDALE AZ 85258
Business Address 9237 E VIA DE VENTURA BLVD., SUITE 105 SCOTTSDALE AZ 85258 480-434-6670
Journey Medical Corp (Filer) CIK: 0001867066 (see all company filings)

IRS No.: 471879539 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41063 | Film No.: 241198195
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)